Abbott Joins Gene Logic’s Stable Of Pharma Partners
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott could pay Gene Logic as much as $100 million in milestones for each drug candidate that is eventually marketed, firm tells “The Pink Sheet” DAILY.